Literature DB >> 10914354

Review of immune function, healing of pressure ulcers, and nutritional status in patients with spinal cord injury.

J M Cruse1, R E Lewis, S Dilioglou, D L Roe, W F Wallace, R S Chen.   

Abstract

The immune, neural, and endocrine systems do not act autonomously; rather, multiple communicative pathways exist among the nervous, endocrine, and immune systems that facilitate physiological immunoregulation. Patients with spinal cord injury (SCI) have decreased natural and adaptive immune responses by 2 weeks after injury. In patients with SCI, adrenocorticotropic hormone (ACTH) and urine-free cortisol levels were increased while zinc and albumin levels were decreased, respectively. In addition, the surface markers alpha 2, alpha 3, alpha 4, CD11a, CD11b, CD18, CD54, and CD8 found on lymphocytes and alpha 3, alpha 4, CD11a, CD18, and CD8 surface markers found on granulocytes were also decreased in the patient population. Finally, the adhesion molecules binding ability in the SCI group was also decreased when compared with a control group. Overall, the investigation showed that patients with SCI have a decreased immune function, especially succeeding the SCI injury, an impaired nutrition status, and a decreased number of adhesion molecules, all of which contribute to delayed wound healing.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10914354     DOI: 10.1080/10790268.2000.11753520

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   1.985


  22 in total

1.  Acute effects of simultaneous electromyostimulation and vibration on leg blood flow in spinal cord injury.

Authors:  H Menéndez; C Ferrero; J Martín-Hernández; A Figueroa; P J Marín; A J Herrero
Journal:  Spinal Cord       Date:  2015-10-13       Impact factor: 2.772

2.  Chronic effects of simultaneous electromyostimulation and vibration on leg blood flow in spinal cord injury.

Authors:  H Menéndez; C Ferrero; J Martín-Hernández; A Figueroa; P J Marín; A J Herrero
Journal:  Spinal Cord       Date:  2016-05-03       Impact factor: 2.772

3.  Anti-alpha4beta1 integrin antibody induces receptor internalization and does not impair the function of circulating neutrophilic leukocytes.

Authors:  Jennifer C Fleming; Feng Bao; Gediminas Cepinskas; Lynne C Weaver
Journal:  Inflamm Res       Date:  2010-03-07       Impact factor: 4.575

4.  Impaired immune responses following spinal cord injury lead to reduced ability to control viral infection.

Authors:  Katherine S Held; Oswald Steward; Caroline Blanc; Thomas E Lane
Journal:  Exp Neurol       Date:  2010-09-09       Impact factor: 5.330

5.  Comparison of nutritional intake between individuals with acute and chronic spinal cord injury.

Authors:  Claudio Perret; Nadine Stoffel-Kurt
Journal:  J Spinal Cord Med       Date:  2011-11       Impact factor: 1.985

6.  Fatal Septicaemia Following Suprapubic Cystostomy in a Paraplegic Patient: Never Do a Cystostomy without Prior Urine Culture and Appropriate Antibiogram!

Authors:  Subramanian Vaidyanathan; Bakul M Soni; Tun Oo; Peter L Hughes; Gurpreet Singh
Journal:  Case Rep Med       Date:  2010-06-10

7.  A pilot study evaluating protein abundance in pressure ulcer fluid from people with and without spinal cord injury.

Authors:  Laura E Edsberg; Jennifer T Wyffels; Rajna Ogrin; B Catharine Craven; Pamela Houghton
Journal:  J Spinal Cord Med       Date:  2014-06-26       Impact factor: 1.985

Review 8.  Exercise recommendations for individuals with spinal cord injury.

Authors:  Patrick L Jacobs; Mark S Nash
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

9.  Spinal Cord Injury Suppresses Cutaneous Inflammation: Implications for Peripheral Wound Healing.

Authors:  Jessica M Marbourg; Anna Bratasz; Xiaokui Mo; Phillip G Popovich
Journal:  J Neurotrauma       Date:  2016-10-17       Impact factor: 5.269

Review 10.  Spinal cord injury, immunodepression, and antigenic challenge.

Authors:  Katherine S Held; Thomas E Lane
Journal:  Semin Immunol       Date:  2014-04-18       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.